Factors associated with thrombocytopenia in patients treated with pegfilgrastim.

Fumihiro Nishimura,Tomoko Ushijima,Shinsuke Hamada,Shigeyuki Miyamura,Kentaro Oniki,Junji Saruwatari

International journal of clinical pharmacology and therapeutics（2023）

引用 0|浏览6

暂无评分

摘要

Thrombocytopenia due to pegfilgrastim administered as primary prophylaxis for FN with cabazitaxel was most likely to occur within one week after pegfilgrastim administration, suggesting that monocytes, neutrophils, and liver metastases were associated with a reduction in platelets.

查看译文

关键词

pegfilgrastim,thrombo,cytopenia,cabazitaxel,prostate cancer,febrile neutropenia

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要